Director: Mitch A. Phelps, PhD

The Pharmacoanalytic Shared Resource (PhASR) supports pre-clinical and clinical drug development at The Ohio State University by providing high quality and cost-effective bioanalytical method development, quantitative sample analysis, and pharmacokinetic/pharmacodynamic experimental design, data analysis and modeling. Expertise among the PhASR personnel includes quantitative pharmacology; bioanalytical methodology, design of pharmacokinetic/pharmacodynamic studies in animal disease models and in humans enrolled in clinical trials; data analysis and modeling of PK/PD data to inform drug development decisions. The PhASR personnel are available for consultation on clinical or pre-clinical PK/PD experimental design and analysis.

PhASR's Goals

Provide the OSUCCC – James and broader research and drug development community with:

  • High-quality, state-of-the-art, cost-competitive analytical expertise and instrumentation for quantitation of drugs and metabolites in biological specimens
  • Pharmacokinetic data (real-time when necessary) to enable pharmacologic data to be incorporated into clinical decision-making during dose escalation and interpretation of patient response and toxicity or in pre-clinical drug development efforts
  • Expertise in pharmacokinetic/pharmacodynamic study design and data interpretation during submission of clinical protocols, grant proposals, study reports and publications


Contact PhASR

College of Pharmacy, Division of Pharmaceutics
241 Parks Hall
500 W. 12th Ave.
Columbus, OH 43210

441 Biomedical Research Tower
460 W. 12th Ave.
Columbus, OH 43210

Availability: Monday-Friday, 8 a.m.-5 p.m.

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program


Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator


Find a Scientific Publication